Heggie Theresa's Form 4 filing
Biocryst Pharmaceuticals Inc (BCRX) · filed Aug 15, 2025
- Accession no.
- 0001127602-25-020491
- Filed
- Aug 15, 2025
- Trade date
- Aug 13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $595.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heggie TheresaCIK 0001760020 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Common Stock | MOption exerciseAcquired | +30,000 | $2.91 | +$87,300 | 95,352 | Direct | |
| Aug 13, 2025 | Common Stock | MOption exerciseAcquired | +40,000 | $5.41 | +$216,400 | 135,352 | Direct | |
| Aug 13, 2025 | Common Stock | SSaleDisposed | −70,000 | $8.51 | −$595,700 | 65,352 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 0 | Direct | |
| Aug 13, 2025 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.